DNA X delays quarterly filing over preferred stock accounting
- DNA X delayed its Form 10-Q for the three months ended September 30, 2026, as preferred stock accounting prolonged its financial close.
- The accounting review concerns related-party preferred stock issuances, including whether to classify the stock as mezzanine equity or permanent equity.
- The company expects to file within five calendar days of the prescribed due date.
- Net loss from continuing operations is expected at approximately $1.3 million, versus approximately $2.2 million in the corresponding 2025 period.
- The narrower loss reflects $500,000 in prior-year interest expense on promissory notes repaid in January 2026 and $400,000 in prior-year divestiture-related legal fees.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-052817), on November 17, 2026, and is solely responsible for the information contained therein.